CI The Cigna Group Common Stock
Sobre The Cigna Group Common Stock Visão geral da empresa da Wikipedia
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.
Ler mais
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products will be renamed Healthspring, which was a dormant brand name acquired as part of HCSC deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
CI Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
CI Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor |
|---|---|
| 4 de Junho de 2026 | $1,5600 |
| 5 de Março de 2026 | $1,5600 |
| 4 de Dezembro de 2025 | $1,5100 |
| 4 de Setembro de 2025 | $1,5100 |
| 3 de Junho de 2025 | $1,5100 |
| 5 de Março de 2025 | $1,5100 |
| 4 de Dezembro de 2024 | $1,4000 |
| 4 de Setembro de 2024 | $1,4000 |
| 4 de Junho de 2024 | $1,4000 |
| 5 de Março de 2024 | $1,4000 |
| 5 de Dezembro de 2023 | $1,2300 |
| 5 de Setembro de 2023 | $1,2300 |
| 6 de Junho de 2023 | $1,2300 |
| 7 de Março de 2023 | $1,2300 |
| 5 de Dezembro de 2022 | $1,1200 |
| 6 de Setembro de 2022 | $1,1200 |
| 7 de Junho de 2022 | $1,1200 |
| 8 de Março de 2022 | $1,1200 |
| 6 de Dezembro de 2021 | $1,0000 |
| 7 de Setembro de 2021 | $1,0000 |
CI Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 11 32,4%
- Compra 16 47,1%
- Manter 7 20,6%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
24 analistas · 2026-08-14Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $7.78 | $7.83 | -0.05% |
| 31 de Março de 2026 | $7.79 | $7.84 | -0.05% |
| 31 de Dezembro de 2025 | $8.08 | $8.11 | -0.03% |
| 30 de Setembro de 2025 | $7.83 | $7.88 | -0.05% |
| 30 de Junho de 2025 | $7.20 | $7.37 | -0.17% |
| 31 de Março de 2025 | $6.74 | $6.54 | 0.20% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
Balanço Patrimonial 29
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
Fluxo de Caixa 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
Taxas de Crescimento 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
Demonstração de Resultados 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | -540,074,000 | 267,530,000 | 268,154,000 | 272,953,000 | -568,695,000 | 281,396,000 | 284,052,000 | 286,465,000 | -596,127,000 | 297,131,000 | 296,879,000 | 298,999,000 | -634,038,000 | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
Balanço Patrimonial 28
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
Fluxo de Caixa 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
Avaliação (TTM) 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277.09B | $270.92B | · | $266.12B | $256.90B | $246.97B | · | $230.52B | $215.41B | $201.41B | · | $189.43B | $185.86B | $181.28B | · | $179.05B | |
| Net Income TTM | $6.82B | $6.58B | · | $5.84B | $5.50B | $3.65B | · | $3.69B | $4.38B | $4.05B | · | $7.04B | $7.16B | $6.87B | · | $7.20B | |
| P/E | 10.9 | 11.2 | · | 14.3 | 17.7 | 27.5 | · | 29.2 | 23.4 | 28.1 | · | 12.5 | 12.2 | 11.7 | · | 12.4 | |
| Earnings Yield | 9.2% | 8.9% | · | 7.0% | 5.6% | 3.6% | · | 3.4% | 4.3% | 3.6% | · | 8.0% | 8.2% | 8.5% | · | 8.1% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Margem Operacional % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| Lucro líquido | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| EPS Diluído | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Índice de liquidez corrente | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| Índice de Liquidez Seca | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Últimas notícias Notícias recentes mencionando esta empresa
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 1.887 declarantes · $43.5B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 166 (-17 vs trimestre anterior) | 88 (-28 vs trimestre anterior) | 657 (+16 vs trimestre anterior) | 578 (+1 vs trimestre anterior) | +28.9M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4.762.729.281 | 17.276.296 | 10,94% | Ações |
| STATE STREET CORP | $3.496.245.161 | 12.682.259 | 8,03% | Ações |
| Dodge & Cox | $3.356.093.871 | 12.173.875 | 7,71% | Ações |
| Sanders Capital, LLC | $2.796.668.015 | 10.144.617 | 6,42% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.717.104.307 | 6.228.614 | 3,94% | Ações |
| GQG Partners LLC | $1.628.918.123 | 5.908.707 | 3,74% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.480.812.562 | 5.399.567 | 3,40% | Ações |
| FMR LLC | $1.045.833.560 | 3.793.651 | 2,40% | Ações |
| NORGES BANK | $982.164.860 | 3.562.699 | 2,26% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785.495.575 | 2.849.302 | 1,80% | Ações |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710.448.797 | 2.577.075 | 1,63% | Ações |
| AMERIPRISE FINANCIAL INC | $683.415.995 | 2.478.794 | 1,57% | Ações |
| Davis Selected Advisers | $621.243.564 | 2.253.424 | 1,43% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600.639.178 | 2.178.755 | 1,38% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $599.490.928 | 2.174.590 | 1,38% | Ações |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558.018.223 | 2.024.152 | 1,28% | Ações |
| TWO SIGMA INVESTMENTS, LP | $499.838.165 | 1.813.110 | 1,15% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $409.373.497 | 1.484.959 | 0,94% | Ações |
| Capital World Investors | $365.436.721 | 1.325.583 | 0,84% | Ações |
| Capital Research Global Investors | $340.312.625 | 1.234.448 | 0,78% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $297.765.000 | 1.080.111 | 0,68% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295.639.232 | 1.072.400 | 0,68% | Opção de compra |
| BloombergSen Inc. | $250.400.144 | 908.300 | 0,58% | Opção de compra |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241.311.801 | 875.333 | 0,55% | Ações |
| BlackRock, Inc. | $229.573.898 | 832.755 | 0,53% | Ações |
| RAYMOND JAMES FINANCIAL INC | $223.834.542 | 811.936 | 0,51% | Ações |
| National Pension Service | $218.948.088 | 794.211 | 0,50% | Ações |
| NORDEA INVESTMENT MANAGEMENT AB | $217.176.543 | 782.731 | 0,50% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $210.159.410 | 762.331 | 0,48% | Ações |
| Swiss National Bank | $205.012.464 | 743.661 | 0,47% | Ações |
| LYRICAL ASSET MANAGEMENT LP | $204.993.443 | 743.592 | 0,47% | Ações |
| Caisse de depot et placement du Quebec | $195.590.549 | 709.484 | 0,45% | Ações |
| Swedbank AB | $189.698.992 | 688.113 | 0,44% | Ações |
| NEUBERGER BERMAN GROUP LLC | $187.717.903 | 679.907 | 0,43% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $186.022.799 | 674.778 | 0,43% | Ações |
| Legal & General Group Plc | $182.534.897 | 662.126 | 0,42% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $177.364.388 | 643.370 | 0,41% | Ações |
| Vanguard Global Advisers, LLC | $173.779.299 | 630.366 | 0,40% | Ações |
| Focused Investors LLC | $172.548.112 | 625.900 | 0,40% | Ações |
| GOLDMAN SACHS GROUP INC | $166.646.906 | 604.494 | 0,38% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $163.250.253 | 592.173 | 0,37% | Ações |
| PZENA INVESTMENT MANAGEMENT LLC | $154.942.084 | 562.036 | 0,36% | Ações |
| RHUMBLINE ADVISERS | $150.435.689 | 545.690 | 0,35% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $148.808.756 | 539.788 | 0,34% | Ações |
| PRUDENTIAL FINANCIAL INC | $141.115.078 | 511.880 | 0,32% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $140.128.144 | 508.300 | 0,32% | Opção de venda |
| California Public Employees Retirement System | $138.113.475 | 500.992 | 0,32% | Ações |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $137.040.252 | 497.099 | 0,31% | Ações |
| Walleye Trading LLC | $136.103.216 | 493.700 | 0,31% | Opção de compra |
| ENVESTNET ASSET MANAGEMENT INC | $131.134.728 | 475.677 | 0,30% | Ações |
| JANE STREET GROUP, LLC | $131.058.272 | 475.400 | 0,30% | Opção de venda |
| MILLENNIUM MANAGEMENT LLC | $125.612.214 | 455.645 | 0,29% | Ações |
| Squarepoint Ops LLC | $124.438.920 | 451.389 | 0,29% | Ações |
| BANK OF AMERICA CORP /DE/ | $118.315.239 | 429.176 | 0,27% | Ações |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $117.937.834 | 427.807 | 0,27% | Ações |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $113.641.637 | 412.223 | 0,26% | Ações |
| MENORA MIVTACHIM HOLDINGS LTD. | $108.480.080 | 393.500 | 0,25% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $108.208.205 | 405.654 | 0,25% | Ações |
| Man Group plc | $106.485.811 | 386.266 | 0,24% | Ações |
| JANE STREET GROUP, LLC | $102.359.984 | 371.300 | 0,24% | Opção de compra |
| PARNASSUS INVESTMENTS, LLC | $99.345.699 | 360.366 | 0,23% | Ações |
| HSBC HOLDINGS PLC | $98.445.052 | 357.099 | 0,23% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $97.924.160 | 346.279 | 0,22% | Ações |
| HighTower Advisors, LLC | $97.700.540 | 354.398 | 0,22% | Ações |
| Qube Research & Technologies Ltd | $95.895.839 | 347.852 | 0,22% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $95.247.164 | 345.499 | 0,22% | Ações |
| COOPERMAN LEON G | $89.596.000 | 325.000 | 0,21% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $88.633.118 | 321.070 | 0,20% | Ações |
| UBS Group AG | $85.150.936 | 308.876 | 0,20% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $84.423.968 | 306.239 | 0,19% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $83.067.071 | 301.317 | 0,19% | Ações |
| Brandywine Global Investment Management, LLC | $83.043.221 | 301.723 | 0,19% | Ações |
| BARCLAYS PLC | $81.058.191 | 294.030 | 0,19% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $81.028.968 | 293.924 | 0,19% | Ações |
| CITADEL ADVISORS LLC | $80.415.856 | 291.700 | 0,18% | Opção de compra |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $77.231.334 | 284.500 | 0,18% | Ações |
| D. E. Shaw & Co., Inc. | $77.230.098 | 280.144 | 0,18% | Ações |
| FRANKLIN RESOURCES INC | $74.338.766 | 269.656 | 0,17% | Ações |
| BANK OF NOVA SCOTIA | $73.763.722 | 267.570 | 0,17% | Ações |
| CAPTRUST FINANCIAL ADVISORS | $73.593.768 | 266.954 | 0,17% | Ações |
| Quantinno Capital Management LP | $72.042.853 | 261.327 | 0,17% | Ações |
| LPL Financial LLC | $71.360.823 | 258.854 | 0,16% | Ações |
| ALLIANCEBERNSTEIN L.P. | $70.866.139 | 265.665 | 0,16% | Ações |
| JANE STREET GROUP, LLC | $70.403.434 | 255.381 | 0,16% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $69.152.270 | 259.240 | 0,16% | Ações |
| TD Asset Management Inc | $68.910.627 | 249.966 | 0,16% | Ações |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $67.953.466 | 246.494 | 0,16% | Ações |
| AVIVA PLC | $66.917.736 | 242.737 | 0,15% | Ações |
| Susquehanna Portfolio Strategies, LLC | $65.143.735 | 236.302 | 0,15% | Ações |
| Korea Investment CORP | $64.741.794 | 234.844 | 0,15% | Ações |
| WOLVERINE TRADING, LLC | $64.525.530 | 225.110 | 0,15% | Ações |
| Nuveen Asset Management, LLC | $64.039.904 | 231.911 | 0,15% | Ações |
| PORTLAND INVESTMENT COUNSEL INC. | $62.303.680 | 226.000 | 0,14% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $60.990.065 | 221.235 | 0,14% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $60.432.000 | 219.209 | 0,14% | Ações |
| BARCLAYS PLC | $60.098.240 | 218.000 | 0,14% | Opção de compra |
| Ensign Peak Advisors, Inc | $59.737.375 | 216.691 | 0,14% | Ações |
| CITADEL ADVISORS LLC | $58.912.816 | 213.700 | 0,14% | Opção de venda |
| Walleye Trading LLC | $58.863.745 | 213.522 | 0,14% | Ações |
| FIRST TRUST ADVISORS LP | $57.187.000 | 207.440 | 0,13% | Ações |
Executivos da empresa 39 insiders · 2 diretores · 1 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jamie G Kates | Chief Accounting Officer | 12 de Junho de 2026 M | 2.368 | 0 | 1 | $-268.450 |
| Durga Prasad Koka | EVP, Global CIO | 1 de Junho de 2026 F | 6.552 | 0 | 0 | $0 |
| George Kurian | Conselheiro | 29 de Maio de 2026 A | 3.778 | 0 | 0 | $0 |
| Nicole S Jones | — | 5 de Agosto de 2026 M | 28.557 | 0 | 2 | $-13.927.384 |
| David Cordani | — | 3 de Novembro de 2025 P | 157.935 | 1 | 0 | $999.932 |
| David J Brailer | — | 29 de Agosto de 2025 F | 17.525 | 0 | 0 | $0 |
| Michael J Hennigan | — | 2 de Junho de 2025 A | 568 | 0 | 0 | $0 |
| Neesha Hathi | — | 23 de Abril de 2025 A | 3.369 | 0 | 0 | $0 |
| Philip Ozuah | — | 23 de Abril de 2025 A | 1.801 | 0 | 0 | $0 |
| Elder Granger | — | 23 de Abril de 2025 A | 6.109 | 0 | 0 | $0 |
| Mark B. Mcclellan | — | 23 de Abril de 2025 A | 6.109 | 0 | 0 | $0 |
| Kimberly A. Ross | — | 23 de Abril de 2025 A | 4.512 | 0 | 0 | $0 |
| Kathleen M Mazzarella | — | 23 de Abril de 2025 A | 6.109 | 0 | 0 | $0 |
| Donna F Zarcone | — | 23 de Abril de 2025 A | 26.735 | 0 | 0 | $0 |
| Eric C Wiseman | — | 23 de Abril de 2025 A | 23.158 | 0 | 0 | $0 |
| Eric J Foss | — | 23 de Abril de 2025 A | 35.914 | 0 | 0 | $0 |
| Noelle K Eder | — | 7 de Março de 2025 S | 13.406 | 0 | 0 | $0 |
| Brian C Evanko | — | 28 de Fevereiro de 2025 A | 51.182 | 0 | 0 | $0 |
| Eric P Palmer | — | 28 de Fevereiro de 2025 A | 66.160 | 0 | 0 | $0 |
| William J Delaney III | — | 19 de Agosto de 2024 M | 17.539 | 0 | 0 | $0 |
| Michael W Triplett | — | 12 de Agosto de 2024 M | 32.833 | 0 | 0 | $0 |
| Mary T Hoeltzel | — | 14 de Maio de 2024 M | 2.595 | 0 | 0 | $0 |
| Cynthia Ryan | — | 30 de Agosto de 2023 M | 5.937 | 0 | 0 | $0 |
| Everett Neville | — | 20 de Julho de 2023 M | 5.987 | 0 | 0 | $0 |
| Paul A Sanford | — | 19 de Julho de 2023 S | 8.679 | 0 | 0 | $0 |
| Jason D Sadler | — | 24 de Fevereiro de 2023 A | 47.015 | 0 | 0 | $0 |
| Charles Berg | — | 8 de Fevereiro de 2023 G | — | 0 | 0 | $0 |
| John Partridge | — | 26 de Abril de 2022 A | 28.177 | 0 | 0 | $0 |
| MURABITO JOHN M | — | 1 de Março de 2022 F | 51.226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | — | 30 de Novembro de 2021 A | 20.015 | 0 | 0 | $0 |
| Matthew G Manders | — | 19 de Novembro de 2021 F | 43.488 | 0 | 0 | $0 |
| Timothy C Wentworth | — | 12 de Maio de 2021 G | 29.783 | 0 | 0 | $0 |
| Kristen Lauria | — | 30 de Abril de 2021 F | 2.785 | 0 | 0 | $0 |
| Steven B Miller | — | 26 de Fevereiro de 2021 F | 28.439 | 0 | 0 | $0 |
| William L Roper | — | 26 de Fevereiro de 2021 A | 8.583 | 0 | 0 | $0 |
| Roman Martinez IV | — | 30 de Novembro de 2020 A | 48.839 | 0 | 0 | $0 |
| Mark L Boxer | — | 28 de Fevereiro de 2020 F | 49.191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | — | 13 de Setembro de 2019 S | 13.500 | 0 | 0 | $0 |
| Lisa R Bacus | — | 1 de Março de 2019 F | 24.024 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 232 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 3,97% | 178.358 SH | 8 de Agosto de 2026 | Diário |
| DUSA · Davis Fundamental ETF Trust | 3,26% | 130.244 NS | 30 de Abril de 2026 | N-PORT |
| MDPL · Northern Lights Fund Trust IV | 3,15% | 6.901 NS | 31 de Maio de 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 2,77% | 47.358 NS | 31 de Maio de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,36% | 70.938 NS | 30 de Abril de 2026 | N-PORT |
| MVFD · Northern Lights Fund Trust IV | 2,35% | 9.177 NS | 31 de Maio de 2026 | N-PORT |
| SMRI · EA Series Trust | 2,01% | 37.417 NS | 30 de Abril de 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 1,96% | 406 NS | 30 de Abril de 2026 | N-PORT |
| QDIV · Global X Funds | 1,89% | 2.232 NS | 31 de Maio de 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,74% | 6.505 SH | 8 de Agosto de 2026 | Diário |
| RUNN · Strategic Trust | 1,67% | 20.819 NS | 31 de Maio de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,62% | 97.516 SH | 8 de Agosto de 2026 | Diário |
| QLTY · GMO ETF Trust | 1,60% | 260.100 NS | 31 de Maio de 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 1,59% | 2.485 NS | 30 de Abril de 2026 | N-PORT |
| GMOV · GMO ETF Trust | 1,53% | 5.024 NS | 31 de Maio de 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 1,53% | 29.890 NS | 30 de Abril de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,45% | 40.044 SH | 8 de Agosto de 2026 | Diário |
| PWV · Invesco Exchange-Traded Fund Trust | 1,33% | 84.431 SH | 8 de Agosto de 2026 | Diário |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,30% | 457.452 SH | 8 de Agosto de 2026 | Diário |
| FBCV · FIDELITY COVINGTON TRUST | 1,29% | 7.062 NS | 30 de Abril de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,25% | 123.144 NS | 30 de Abril de 2026 | N-PORT |
| IYH · iShares Trust | 1,17% | 156.344 SH | 8 de Agosto de 2026 | Diário |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,13% | 92.854 SH | 8 de Agosto de 2026 | Diário |
| FFLV · FIDELITY COVINGTON TRUST | 1,12% | 669 NS | 30 de Abril de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,10% | 5.254 NS | 30 de Abril de 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 1,07% | 10.450 NS | 30 de Abril de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,07% | 792.582 SH | 8 de Agosto de 2026 | Diário |
| RXL · ProShares Trust | 1,06% | 2.747 NS | 31 de Maio de 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1,01% | 33.396 NS | 30 de Abril de 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,01% | 1.451 NS | 30 de Abril de 2026 | N-PORT |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0,98% | 1.172 NS | 31 de Maio de 2026 | N-PORT |
| IMCV · iShares Trust | 0,97% | 40.682 SH | 8 de Agosto de 2026 | Diário |
| PALC · Pacer Funds Trust | 0,97% | 7.697 NS | 30 de Abril de 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,95% | 42.432 NS | 30 de Abril de 2026 | N-PORT |
| RFDA · ALPS ETF Trust | 0,95% | 2.980 NS | 31 de Maio de 2026 | N-PORT |
| IXJ · iShares Trust | 0,92% | 139.115 SH | 8 de Agosto de 2026 | Diário |
| VLUE · iShares Trust | 0,90% | 306.977 SH | 8 de Agosto de 2026 | Diário |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,89% | 31.437.177 | 8 de Agosto de 2026 | Diário |
| EQIN · Columbia ETF Trust I | 0,83% | 7.926 NS | 30 de Abril de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,80% | 24.655 SH | 8 de Agosto de 2026 | Diário |
| NULV · Nushares ETF Trust | 0,79% | 56.180 NS | 30 de Abril de 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0,77% | 8.508 NS | 31 de Maio de 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,72% | 5.530 NS | 30 de Abril de 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,67% | 2.343 NS | 30 de Abril de 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,65% | 3.174 NS | 31 de Maio de 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0,64% | 2.817 SH | 8 de Agosto de 2026 | Diário |
| QARP · DBX ETF Trust | 0,64% | 1.727 NS | 29 de Maio de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,63% | 21.306 SH | 8 de Agosto de 2026 | Diário |
| WLDR · Two Roads Shared Trust | 0,62% | 1.524 NS | 30 de Abril de 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,62% | 6.087 NS | 29 de Maio de 2026 | N-PORT |